ESC主席Michel Komajda

　　International Circulation: I understand your presence at this meeting in China is part of a greater effort on the part of ESC. What avenues of co-operation is ESC exploring and why is that co-operation with China so important?
　　《国际循环》：据我所知，您出席中国的这次会议是ESC方面更大努力的一部分。ESC正在探索的合作途径是什么？为什么与中国的合作如此重要？
　　Prof Komajda: Because China is a country with a population of 1.3 billion people and I think we would make mutual gains by understanding better how patients with cardiovascular disease are treated in this country and to make comparisons with the European region so that we can see if there are major differences or not. If there are differences， why is that the case? Are the differences related to economics or other factors? I think it is a very interesting field of research that we should consider， particularly if you are looking at prevention， which is a major issue all over the globe. Nowadays， the so-called rich countries spend a fortune on sophisticated devices but when you look at very simple measures of good lifestyle or secondary prevention in those patients who have experienced myocardial infarction， the reality is that we are far from being in an optimal situation. I think there is a need for comparing what we are doing in the two geographic areas and it is good to collaborate to promote healthy life measures and prevention at large in Asia as well as in Europe. I do believe that we will need to create alliances particularly between Europe and China because we are each facing an epidemic of obesity and diabetes with the potential cardiovascular complications which we would expect to arise twenty years from now. It is on our mutual interest to have an in-depth collaboration in this respect.
　　Komajda教授： 因为中国是一个拥有13亿人口的国家，我认为我们将通过更好地了解在这个国家中如何治疗心血管疾病患者而获得共同收益，并与欧洲地区进行比较以使我们可以看到是否存在重大差异。如果存在差异则为何是这种情况？差异与经济或其他因素有关吗？我认为这是一个我们应该考虑的令人非常感有趣的研究领域，尤其是如果你是在考察预防方面，这是一个遍及全球的重大问题。如今，所谓的富裕国家在先进设备上花费大量金钱，但当你观察极简单的良好生活方式检测指标或者在那些已经经历过心肌梗死的患者中的二级预防，（你会发现）现实是我们离处于最佳状态还很遥远。我认为有必要比较我们在两个地理区域中所正在做的事情，而且一般来说，在亚洲以及在欧洲，合作以促进健康生活措施和预防是件好事。我的确认为，我们将需要建立同盟，尤其是在欧洲和中国之间，因为我们每个人都面对着肥胖和糖尿病的流行以及我们预料从现在起20年会出现的潜在的心血管并发症。在这方面开展深入合作是我们共同的利益所在。